ALXO ALX Oncology Holdings Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$1,22
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,0552-Wochen-Tief
$2,6552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$169M
P/E
-1.6
EPS
$-1.90
Ihre Abzeichen
52W-Spanne
$1–$3
Analystenbewertung
BUY
Kursziel
$5
P/E
-1.6
ROE
-225.0%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ALXO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.22
Marktkapitalisierung (MRQ)
$169M
P/E
-1.6
EPS
$-1.90
ROE
-225.0%
Verschuldungsgrad (MRQ)
0.1
52W-Spanne
$1–$3
ALXO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz·2018-12-31 → 2022-12-31
EPS$-1.902020-12-31 → 2025-12-31
Freier Cashflow$-84M2020-12-31 → 2025-12-31
Nettogewinnmarge·2020-12-31 → 2020-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ALXO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -1.65-Jahres-Durchschnitt ≈-3.9 | ≈-3.9 | · | · | |
| P/S | 45.25-Jahres-Durchschnitt ≈79.8 | ≈79.8 | 7.8 | Überbewertet | |
| K/B (MRQ) | 1.25-Jahres-Durchschnitt ≈2.2 | ≈2.2 | 2.1 | Fairer Wert | |
| EV / EBITDA (TTM) | -0.55-Jahres-Durchschnitt ≈-1.3 | ≈-1.3 | · | · | |
| Kurs / FCF (TTM) | -2.45-Jahres-Durchschnitt ≈-5.0 | ≈-5.0 | · | · | |
| Kurs / Cashflow (TTM) | -2.45-Jahres-Durchschnitt ≈-5.0 | ≈-5.0 | · | · | |
| EV / Revenue (EV / Umsatz) | 35.85-Jahres-Durchschnitt ≈50.7 | ≈50.7 | · | · | |
| EV / FCF (TTM) | -0.65-Jahres-Durchschnitt ≈-1.7 | ≈-1.7 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 6.55-Jahres-Durchschnitt ≈2.2 | ≈2.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ALXO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -98.3%5-Jahres-Durchschnitt ≈-56.5% | ≈-56.5% | -33.9% | Schwach | |
| ROE | -225.0%5-Jahres-Durchschnitt ≈-97.9% | ≈-97.9% | -39.8% | Schwach | |
| ROIC | -291.1%5-Jahres-Durchschnitt ≈-120.3% | ≈-120.3% | -63.5% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ALXO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.15-Jahres-Durchschnitt ≈0.1 | ≈0.1 | · | · | |
| Liquiditätsgrad (MRQ) | 9.75-Jahres-Durchschnitt ≈9.6 | ≈9.6 | 8.8 | Im Einklang | |
| Quick Ratio | 1.85-Jahres-Durchschnitt ≈9.4 | ≈9.4 | 8.6 | Im Einklang | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.15-Jahres-Durchschnitt ≈0.1 | ≈0.1 | · | · | |
| Interest Coverage (Zinsdeckungsgrad) | -64.95-Jahres-Durchschnitt ≈-85.4 | ≈-85.4 | -165.2 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
3.0%
Nächster Bericht
Nov 05, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-0.12 | $-0.15 | 17.9% |
| 31. März 2026 | $-0.15 | $-0.20 | 26.2% | |
| 31. Dezember 2025 | $-0.37 | $-0.37 | -0.08% | |
| 30. September 2025 | $-0.41 | $-0.37 | -9.6% | |
| 30. Juni 2025 | $-0.43 | $-0.46 | 6.3% | |
| 31. März 2025 | $-0.58 | $-0.47 | -22.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $0 | $1M | $5M | |
| R&D Expense | $77M | $116M | $142M | $98M | $60M | $29M | $16M | |
| SG&A Expense | $24M | $26M | $28M | $29M | $23M | $15M | $3M | |
| Operating Expenses | $104M | $142M | $170M | $127M | $84M | $45M | $24M | |
| Operating Income | $-104M | $-142M | $-170M | $-127M | $-84M | $-44M | $-19M | |
| Interest Expense | $2M | $2M | $2M | $238.0K | $13.0K | · | · | |
| Interest Income | $4M | $9M | $11M | $4M | $91.0K | · | · | |
| Other Non-op | $-36.0K | $-20.0K | $389.0K | $-22.0K | $-7.0K | $-1M | $-5.0K | |
| Pretax Income | $-102M | $-135M | $-161M | $-123M | $-83M | $-45M | $-19M | |
| Income Tax | $0 | $0 | $0 | $64.0K | $-21.0K | $241.0K | $34.0K | |
| Net Income | $-102M | $-135M | $-161M | $-123M | $-83M | $-46M | $-19M | |
| EPS (Basic) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · | |
| EPS (Diluted) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · | |
| Shares (Basic) | 53,658,399 | 52,174,904 | 42,987,767 | 40,699,612 | 40,308,050 | 18,485,343 | 3,076,461 | |
| Shares (Diluted) | 53,658,399 | 52,174,904 | 42,987,767 | 40,699,612 | 40,308,050 | 18,485,343 | · | |
| EBITDA | $-103M | $-142M | $-169M | $-127M | $-84M | $-43M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $18M | $22M | $49M | $364M | $434M | $9M | |
| Short-term Investments | $28M | $110M | $160M | $217M | · | · | · | |
| Prepaid Expense | $6M | $7M | $6M | $5M | $3M | $2M | $256.0K | |
| Other Current Assets | $20.0K | $27.0K | $439.0K | · | · | · | · | |
| Current Assets | $51M | $134M | $189M | $271M | $367M | $436M | $10M | |
| PP&E (Net) | $1M | $3M | $4M | $4M | $897.0K | $52.0K | $860.0K | |
| PP&E (Gross) | $3M | $5M | $5M | $4M | $960.0K | $77.0K | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | $403.0K | $63.0K | $25.0K | $1M | |
| Other Non-current Assets | $4M | $7M | $15M | $15M | $12M | $10.0K | $7.0K | |
| Total Assets | $59M | $148M | $243M | $306M | $380M | $436M | $11M | |
| Accounts Payable | $5M | $4M | $9M | $8M | $4M | $4.0K | $4M | |
| Current Liabilities | $25M | $18M | $36M | $28M | $15M | $6M | $5M | |
| Capital Leases | $3M | $3M | $4M | $5M | $2M | · | · | |
| Other Non-current Liabilities | $4M | $6M | $7M | $5M | $2M | $5.0K | $547.0K | |
| Total Liabilities | $33M | $34M | $53M | $43M | $17M | $6M | $11M | |
| Long-term Debt | $10M | $11M | $11M | $11M | · | · | · | |
| Total Debt | $10M | $10M | $10M | $9M | · | · | · | |
| Common Stock | $54.0K | $53.0K | $50.0K | $41.0K | $41.0K | $40.0K | $3.0K | |
| Retained Earnings | $-723M | $-621M | $-486M | $-325M | $-202M | $-119M | $-73M | |
| AOCI | $28.0K | $275.0K | $256.0K | $-845.0K | · | · | · | |
| Stockholders' Equity | $26M | $114M | $190M | $263M | $363M | $430M | $-71M | |
| Liabilities + Equity | $59M | $148M | $243M | $306M | $380M | $436M | $11M | |
| Shares Outstanding | 54,388,022 | 53,052,912 | 49,951,989 | 40,861,386 | 40,587,067 | 39,844,522 | 3,166,946 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $706.0K | $872.0K | $836.0K | $342.0K | $51.0K | $202.0K | $429.0K | |
| Stock-based Comp | $13M | $27M | $26M | $24M | $14M | $5M | $297.0K | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | $4M | $-15M | $3M | $10M | $1M | $2M | · | |
| Operating Cash Flow | $-84M | $-122M | $-130M | $-89M | $-68M | $-38M | $-14M | |
| CapEx | $212.0K | $447.0K | $1M | $1M | $666.0K | $31.0K | $353.0K | |
| Investing Cash Flow | $83M | $86M | $45M | $-235M | $-5M | $610.0K | $-353.0K | |
| Stock Issued | $2M | $30M | · | · | · | $368M | · | |
| Net Stock Activity | $2M | $30M | · | · | · | $368M | · | |
| Financing Cash Flow | $362.0K | $31M | $59M | $10M | $2M | $463M | $15M | |
| Free Cash Flow | $-84M | $-122M | $-132M | $-91M | $-69M | $-38M | · | |
| Levered FCF | $-86M | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -3694.0% | · | |
| Net Margin | · | · | · | · | · | -3869.7% | · | |
| Pretax Margin | · | · | · | · | · | -3849.3% | · | |
| EBITDA Margin | · | · | · | · | · | -3676.9% | · | |
| ROA | -98.3% | -69.1% | -58.6% | -36.0% | -20.4% | -20.5% | · | |
| ROE | -225.0% | -107.7% | -89.7% | -44.9% | -22.3% | -13.4% | · | |
| ROIC | -291.1% | · | · | -46.7% | -23.0% | -10.2% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 7.3 | 5.2 | 9.6 | 24.0 | 70.3 | · | |
| Quick Ratio | 1.8 | 6.9 | 5.1 | 9.4 | 23.8 | 70.0 | · | |
| Debt / Equity | 0.4 | 0.1 | 0.1 | 0.0 | · | · | · | |
| LT Debt / Equity | 0.2 | 0.1 | 0.1 | 0.0 | · | · | · | |
| Interest Coverage | -64.9 | -82.4 | -108.8 | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | · | 0.0 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.48 | $2.14 | $3.80 | $6.45 | $8.94 | $10.79 | · | |
| Revenue / Share | · | · | · | $0.00 | · | · | · | |
| Cash Flow / Share | $-1.57 | $-2.34 | $-3.03 | $-2.19 | · | · | · | |
| Cash / Share | $0.30 | $0.33 | $0.45 | $1.19 | $8.96 | $10.90 | · | |
| EPS (TTM) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | $4M | $0 | $0 | $1M | · | |
| Net Income TTM | $-102M | $-135M | $-161M | $-123M | $-83M | $-46M | · | |
| Market Cap | $61M | $89M | $744M | $461M | $872M | $3.43B | · | |
| Enterprise Value | $26M | $-29M | $571M | $204M | · | · | · | |
| P/E | -0.6 | -0.6 | -4.0 | -3.7 | -10.4 | -31.2 | · | |
| P/S | 16.5 | 23.7 | 199.2 | · | · | 2905.8 | · | |
| P/B | 2.4 | 0.8 | 3.9 | 1.7 | 2.4 | 8.0 | · | |
| P / Tangible Book | 2.4 | 0.8 | 3.9 | 1.7 | 2.4 | 8.0 | · | |
| P / Cash Flow | -0.7 | -0.7 | -5.7 | -5.2 | -12.8 | -89.7 | · | |
| P / FCF | -0.7 | -0.7 | -5.7 | -5.1 | -12.7 | -89.6 | · | |
| EV / EBITDA | -0.3 | 0.2 | -3.4 | -1.6 | · | · | · | |
| EV / FCF | -0.3 | 0.2 | -4.3 | -2.2 | · | · | · | |
| EV / Revenue | 7.1 | -7.8 | 152.9 | · | · | · | · | |
| Earnings Yield | -168.1% | -154.5% | -25.1% | -26.9% | -9.6% | -3.2% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $14M | $18M | $17M | $18M | $24M | $24M | $26M | $35M | $32M | $46M | $29M | $25M | $29M | $27M | $17M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $8M | $7M | $6M | $7M | $6M | $8M | $7M | $7M | $7M | $7M | $8M | |
| Operating Expenses | $18M | $19M | $23M | $23M | $27M | $32M | $31M | $33M | $42M | $38M | $53M | $37M | $32M | $37M | $34M | $25M | |
| Operating Income | $-18M | $-19M | $-23M | $-23M | $-27M | $-32M | $-31M | $-33M | $-42M | $-38M | $-53M | $-37M | $-32M | $-37M | $-34M | $-25M | |
| Interest Expense | $285.0K | $331.0K | $383.0K | $408.0K | $405.0K | $406.0K | $427.0K | $446.0K | $429.0K | $427.0K | $391.0K | $372.0K | $387.0K | $2.0K | $2.0K | $3.0K | |
| Interest Income | $2M | $1M | $573.0K | $802.0K | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $1M | $876.0K | $225.0K | |
| Other Non-op | $-257.0K | $188.0K | $-17.0K | $-6.0K | $-2.0K | $-11.0K | $-1.0K | $3.0K | $-8.0K | $-14.0K | $-1.0K | $324.0K | $95.0K | $-7.0K | $-5.0K | $-8.0K | |
| Net Income | $-18M | $-18M | $-23M | $-22M | $-26M | $-31M | $-29M | $-31M | $-39M | $-36M | $-51M | $-34M | $-30M | $-35M | $-33M | $-25M | |
| EPS (Basic) | $-0.13 | $-0.17 | $-0.42 | $-0.41 | $-0.49 | $-0.58 | $-0.53 | $-0.58 | $-0.76 | $-0.71 | $-1.24 | $-0.84 | $-0.74 | $-0.87 | $-0.81 | $-0.60 | |
| EPS (Diluted) | $-0.13 | $-0.17 | $-0.42 | $-0.41 | $-0.49 | $-0.58 | $-0.53 | $-0.58 | $-0.76 | $-0.71 | $-1.24 | $-0.84 | $-0.74 | $-0.87 | $-0.81 | $-0.60 | |
| Shares (Basic) | 135,639,684 | 104,573,657 | · | 53,577,066 | 53,445,631 | 53,359,338 | · | 52,693,878 | 51,831,157 | 50,120,758 | 41,147,938 | 40,875,457 | 40,862,513 | 40,747,026 | 40,687,751 | 40,616,302 | |
| Shares (Diluted) | 135,639,684 | 104,573,657 | · | 53,577,066 | 53,445,631 | 53,359,338 | · | 52,693,878 | 51,831,157 | 50,120,758 | 41,147,938 | 40,875,457 | 40,862,513 | 40,747,026 | 40,687,751 | 40,616,302 | |
| EBITDA | $-18M | $-19M | · | $-23M | $-27M | $-32M | · | $-33M | $-42M | $-38M | $-53M | $-37M | $-32M | $-37M | $-34M | · |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $32M | $16M | $23M | $19M | $21M | $18M | $16M | $16M | $14M | $20M | $38M | $63M | $49M | $66M | $159M | |
| Short-term Investments | $116M | $108M | $28M | $37M | $60M | $77M | $110M | $132M | $141M | $143M | $170M | $175M | $165M | $236M | $247M | $158M | |
| Prepaid Expense | $5M | $5M | $6M | $6M | $6M | $5M | $7M | $7M | $12M | $10M | $9M | $7M | $5M | $6M | $3M | $5M | |
| Other Current Assets | $542.0K | $25.0K | $20.0K | · | $4.0K | · | $27.0K | $1M | $315.0K | · | · | · | · | · | · | · | |
| Current Assets | $143M | $146M | $51M | $67M | $85M | $103M | $134M | $156M | $169M | $168M | $199M | $220M | $233M | $291M | $317M | $322M | |
| PP&E (Net) | $166.0K | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $2M | $2M | $1M | |
| PP&E (Gross) | $1M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $3M | $2M | $1M | |
| Accum. Depreciation | $938.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $823.0K | $616.0K | $300.0K | $205.0K | $121.0K | |
| Other Non-current Assets | $2M | $3M | $4M | $9M | $4M | $7M | $7M | $13M | $13M | $14M | $11M | $11M | $13M | $16M | $17M | $16M | |
| Total Assets | $161M | $178M | $59M | $83M | $95M | $121M | $148M | $186M | $215M | $213M | $220M | $246M | $278M | $318M | $346M | $364M | |
| Accounts Payable | $3M | $4M | $5M | $7M | $5M | $4M | $4M | $8M | $8M | $6M | $13M | $4M | $10M | $6M | $9M | $5M | |
| Current Liabilities | $15M | $20M | $25M | $28M | $19M | $19M | $18M | $32M | $38M | $32M | $35M | $18M | $22M | $25M | $24M | $15M | |
| Capital Leases | $0 | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $5M | |
| Other Non-current Liabilities | $152.0K | $4M | $4M | $4M | $5M | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $6M | $5M | $6M | $5M | |
| Total Liabilities | $25M | $27M | $33M | $38M | $31M | $33M | $34M | $49M | $55M | $48M | $51M | $33M | $38M | $31M | $30M | $20M | |
| Long-term Debt | $10M | $9M | $10M | $11M | $11M | $11M | $10M | $11M | $11M | $11M | $11M | $11M | $11M | · | · | · | |
| Total Debt | $10M | $9M | · | $10M | $10M | $10M | · | $10M | $10M | $10M | $10M | $10M | $9M | · | · | · | |
| Common Stock | $138.0K | $135.0K | $54.0K | $54.0K | $54.0K | $53.0K | $53.0K | $53.0K | $52.0K | $50.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | |
| Retained Earnings | $-759M | $-741M | $-723M | $-700M | $-678M | $-652M | $-621M | $-592M | $-561M | $-522M | $-441M | $-390M | $-356M | $-295M | $-259M | $-227M | |
| AOCI | $-224.0K | $-245.0K | $28.0K | $43.0K | $36.0K | $118.0K | $275.0K | $563.0K | $-73.0K | $28.0K | $-226.0K | $-312.0K | $-88.0K | $-2M | $-1M | $-606.0K | |
| Stockholders' Equity | $136M | $151M | $26M | $45M | $64M | $88M | $114M | $137M | $159M | $164M | $169M | $213M | $240M | $287M | $316M | $344M | |
| Liabilities + Equity | $161M | $178M | $59M | $83M | $95M | $121M | $148M | $186M | $215M | $213M | $220M | $246M | $278M | $318M | $346M | $364M | |
| Shares Outstanding | 138,216,247 | 134,540,741 | 54,388,022 | 53,577,566 | 53,506,777 | 53,384,145 | 53,052,912 | 52,743,104 | 52,452,749 | 50,277,193 | 41,151,819 | 40,992,179 | 40,863,049 | 40,748,290 | 40,745,252 | 40,656,632 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $86.0K | $150.0K | $151.0K | $153.0K | $191.0K | $211.0K | $214.0K | $224.0K | $220.0K | $214.0K | $209.0K | $207.0K | $213.0K | $95.0K | $84.0K | $58.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $2M | $5M | $6M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | |
| Other Non-cash | · | $-3M | · | · | · | $664.0K | · | · | · | $-10M | · | · | $-4M | · | · | · | |
| Operating Cash Flow | $-16M | $-19M | $-19M | $-17M | $-23M | $-25M | $-32M | $-25M | $-27M | $-38M | $-31M | $-32M | $-28M | $-31M | $-17M | $-21M | |
| CapEx | $17.0K | $50.0K | $49.0K | $56.0K | $47.0K | $60.0K | $60.0K | $149.0K | $90.0K | $148.0K | $-1M | $2M | $690.0K | $192.0K | $257.0K | $589.0K | |
| Investing Cash Flow | $7M | $-105M | $11M | $21M | $22M | $28M | $33M | $26M | $907.0K | $26M | $13M | $6M | $42M | $14M | $-76M | $-184M | |
| Stock Issued | $0 | $11.0K | $1M | $0 | $0 | $372.0K | $359.0K | $75.0K | $26M | $3M | · | · | · | · | · | · | |
| Net Stock Activity | · | $11.0K | · | · | · | $372.0K | · | · | · | $3M | · | · | · | · | · | · | |
| Financing Cash Flow | $137.0K | $140M | $678.0K | $-159.0K | $-222.0K | $65.0K | $328.0K | $251.0K | $27M | $3M | $-111.0K | $343.0K | $-107.0K | $-136.0K | $422.0K | $80.0K | |
| Free Cash Flow | · | $-19M | · | · | · | $-25M | · | · | · | $-38M | · | · | $-29M | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.0% | -12.0% | · | -16.5% | -16.7% | -18.4% | · | -15.1% | -17.1% | -14.5% | -19.0% | -11.5% | -9.4% | -9.8% | -8.6% | · | |
| ROE | -17.9% | -15.0% | · | -24.4% | -23.2% | -24.4% | · | -20.1% | -21.2% | -17.6% | -22.4% | -12.9% | -10.3% | -10.5% | -9.1% | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | 7.2 | · | 2.4 | 4.5 | 5.5 | · | 4.8 | 4.4 | 5.2 | 5.7 | 12.5 | 10.6 | 11.5 | 13.2 | · | |
| Quick Ratio | 9.4 | 7.0 | · | 2.2 | 4.2 | 5.2 | · | 4.6 | 4.1 | 4.9 | 5.4 | 12.1 | 10.4 | 11.3 | 13.1 | · | |
| Debt / Equity | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | · | · | · | |
| LT Debt / Equity | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | · | · | · | |
| Interest Coverage | -63.3 | -57.3 | · | -55.2 | -65.8 | -78.4 | · | -73.0 | -96.8 | -88.4 | -136.3 | -98.9 | -83.2 | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.99 | $1.12 | · | $0.84 | $1.20 | $1.65 | · | $2.59 | $3.04 | $3.27 | $4.10 | $5.19 | $5.88 | $7.04 | $7.76 | · | |
| Cash Flow / Share | · | $-0.18 | · | · | · | $-0.46 | · | · | · | $-0.76 | · | · | $-0.68 | · | · | · | |
| Cash / Share | $0.16 | $0.24 | · | $0.44 | $0.36 | $0.39 | · | $0.31 | $0.30 | $0.28 | $0.48 | $0.93 | $1.55 | $1.20 | $1.63 | · | |
| EPS (TTM) | $-1.13 | $-1.49 | · | $-2.01 | $-2.18 | $-2.45 | · | $-2.97 | $-3.63 | $-3.71 | $-3.57 | $-3.20 | $-3.17 | $-2.98 | $-2.72 | $-2.31 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $1M | $1M | $1M | · | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Net Income TTM | $-81M | $-89M | · | $-108M | $-117M | $-130M | · | $-151M | $-171M | $-166M | $-146M | $-130M | $-129M | $-121M | $-110M | $-94M | |
| Market Cap | $286M | $270M | · | $98M | $22M | $33M | · | $96M | $316M | $561M | $198M | $308M | $185M | $390M | $330M | · | |
| Enterprise Value | $158M | $138M | · | $48M | $-47M | $-55M | · | $-43M | $169M | $413M | $17M | $105M | $-34M | · | · | · | |
| P/E | -1.8 | -1.3 | · | -0.9 | -0.2 | -0.3 | · | -0.6 | -1.7 | -3.0 | -1.3 | -2.3 | -1.4 | -3.2 | -3.0 | -7.3 | |
| P/S | 242.1 | 228.2 | · | 83.0 | 18.8 | 28.1 | · | 81.2 | 267.6 | 474.3 | 167.1 | 260.4 | 156.3 | 329.9 | 278.9 | · | |
| P/B | 2.1 | 1.8 | · | 2.2 | 0.3 | 0.4 | · | 0.7 | 2.0 | 3.4 | 1.2 | 1.4 | 0.8 | 1.4 | 1.0 | · | |
| P / Tangible Book | 2.1 | 1.8 | · | 2.2 | 0.3 | 0.4 | · | 0.7 | 2.0 | 3.4 | 1.2 | 1.4 | 0.8 | 1.4 | 1.0 | 2.0 | |
| P / Cash Flow | · | -14.5 | · | · | · | -1.3 | · | · | · | -14.8 | · | · | -6.6 | · | · | · | |
| EV / Revenue | 133.3 | 116.7 | · | 40.2 | -39.8 | -46.2 | · | -36.2 | 143.3 | 349.3 | 14.5 | 88.4 | -28.6 | · | · | · | |
| Earnings Yield | -54.6% | -74.3% | · | -109.8% | -525.3% | -393.3% | · | -163.2% | -60.2% | -33.3% | -74.4% | -42.6% | -70.1% | -31.1% | -33.6% | -13.7% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | · | · | · | $0 | $0 |
| Nettoergebnis | $-102M | $-135M | $-161M | $-123M | $-83M |
| Verwässerte EPS | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.4 | 0.1 | 0.1 | 0.0 | · |
| Liquiditätsgrad | 2.1 | 7.3 | 5.2 | 9.6 | 24.0 |
| Quick Ratio | 1.8 | 6.9 | 5.1 | 9.4 | 23.8 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-84M | $-122M | $-132M | $-91M | $-69M |
Institutionelle Eigentümer (13F) 100 Einreicher · $216.9M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
100
Gehaltener Wert
$216.9M
Neue Positionen
38
Geschlossene Positionen
11
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 38 (+14 vs. Vorquartal) | 11 (+1 vs. Vorquartal) | 28 (+10 vs. Vorquartal) | 11 (-2 vs. Vorquartal) | +16.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $26.934.527 | 13.011.849 | 12,42% | Aktien |
| venBio Partners LLC | $26.671.201 | 12.884.638 | 12,29% | Aktien |
| BlackRock, Inc. | $15.317.028 | 7.399.530 | 7,06% | Aktien |
| Redmile Group, LLC | $15.302.483 | 7.392.504 | 7,05% | Aktien |
| Blackstone Inc. | $13.648.634 | 6.593.543 | 6,29% | Aktien |
| Driehaus Capital Management LLC | $12.472.247 | 6.025.240 | 5,75% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $11.891.647 | 5.744.757 | 5,48% | Aktien |
| TCG Crossover Management, LLC | $11.706.858 | 5.655.487 | 5,40% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.295.013 | 4.973.436 | 4,75% | Aktien |
| Vivo Capital, LLC | $6.592.356 | 3.184.713 | 3,04% | Aktien |
| MARSHALL WACE, LLP | $6.357.997 | 3.071.496 | 2,93% | Aktien |
| 5AM Venture Management, LLC | $6.328.663 | 3.057.325 | 2,92% | Aktien |
| Almitas Capital LLC | $6.082.552 | 2.938.431 | 2,80% | Aktien |
| ORBIMED ADVISORS LLC | $5.933.150 | 2.866.256 | 2,74% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $5.771.224 | 2.787.809 | 2,66% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $4.508.824 | 2.178.176 | 2,08% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $3.195.240 | 1.543.594 | 1,47% | Aktien |
| STATE STREET CORP | $3.102.733 | 1.498.905 | 1,43% | Aktien |
| JPMORGAN CHASE & CO | $2.298.401 | 1.044.728 | 1,06% | Aktien |
| NORTHERN TRUST CORP | $1.936.835 | 935.669 | 0,89% | Aktien |
| VANGUARD GROUP INC | $1.842.962 | 1.630.940 | 0,85% | Aktien |
| Ensign Peak Advisors, Inc | $1.677.315 | 810.297 | 0,77% | Aktien |
| Nantahala Capital Management, LLC | $1.552.500 | 750.000 | 0,72% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.550.904 | 749.229 | 0,71% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.539.026 | 743.491 | 0,71% | Aktien |
| GOLDMAN SACHS GROUP INC | $1.536.625 | 742.331 | 0,71% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.249.860 | 603.797 | 0,58% | Aktien |
| ADAR1 Capital Management, LLC | $1.104.676 | 533.660 | 0,51% | Aktien |
| UBS Group AG | $958.292 | 462.943 | 0,44% | Aktien |
| TWO SIGMA ADVISERS, LP | $802.752 | 710.400 | 0,37% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $499.104 | 241.113 | 0,23% | Aktien |
| Bank of New York Mellon Corp | $493.585 | 238.447 | 0,23% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $467.969 | 226.072 | 0,22% | Aktien |
| Atom Investors LP | $454.121 | 219.382 | 0,21% | Aktien |
| IEQ CAPITAL, LLC | $363.041 | 175.382 | 0,17% | Aktien |
| MORGAN STANLEY | $326.798 | 157.873 | 0,15% | Aktien |
| Invesco Ltd. | $310.341 | 149.923 | 0,14% | Aktien |
| Nuveen, LLC | $297.345 | 143.645 | 0,14% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $254.935 | 123.157 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $223.350 | 107.902 | 0,10% | Aktien |
| DEUTSCHE BANK AG\ | $222.376 | 107.428 | 0,10% | Aktien |
| WELLS FARGO & COMPANY/MN | $206.847 | 99.926 | 0,10% | Aktien |
| Verdad Advisers, LP | $170.154 | 82.200 | 0,08% | Aktien |
| BANK OF AMERICA CORP /DE/ | $157.386 | 76.032 | 0,07% | Aktien |
| Graham Capital Management, L.P. | $154.879 | 74.821 | 0,07% | Aktien |
| XTX Topco Ltd | $144.190 | 69.657 | 0,07% | Aktien |
| MetLife Investment Management, LLC | $134.465 | 64.959 | 0,06% | Aktien |
| CITIGROUP INC | $104.815 | 50.635 | 0,05% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $102.842 | 49.682 | 0,05% | Aktien |
| Squarepoint Ops LLC | $97.019 | 46.869 | 0,04% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| LSV Associates, LLC, Lightstone Ventures, L.P., Lightstone Ventures (A), L.P., LSV Associates II, LLC, Lightstone Ventures II, L.P., Lightstone Ventures II (A), L.P., Michael A Carusi, Jean George, Henry A. Plain Jr | 27. Mai 2026 | 2,20% | Änderung | · | SEC |
| venBio Global Strategic Fund, L.P., venBio Global Strategic Fund II L.P., venBio Global Strategic GP, L.P., venBio Global Strategic GP II, L.P., venBio Global Strategic GP, Ltd., venBio Global Strategic GP II, Ltd., Adelman Robert J, GOODMAN COREY S ×2 Einreichungen | 4. Februar 2026 | 10,00% | Änderung | · | SEC |
| Lightstone Ventures, L.P., Lightstone Ventures (A), L.P., LSV Associates, LLC, Lightstone Ventures II, L.P., Lightstone Ventures II (A), L.P., LSV Associates II, LLC, Michael A. Carusi, Jean M. George, Henry A. Plain, Jr. ×3 Einreichungen | 14. Februar 2024 | · | Erste Einreichung | · | SEC |
| Logos Global Management LP, Logos Global Management GP LLC, Arsani William, Graham Walmsley, Logos Opportunities Fund I LP, Logos Opportunities GP LLC, Logos GP LLC ×2 Einreichungen | 15. Juni 2021 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 19 Insider · 10 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jason Lettmann | CHIEF EXECUTIVE OFFICER | 17. August 2026 S | 294.379 | 0 | 2 | $-31.019 |
| Harish Shantharam | Chief Financial Officer | 26. Januar 2026 A | 75.000 | 0 | 0 | $0 |
| Peter S Garcia | CHIEF FINANCIAL OFFICER | 14. August 2024 F | 121.516 | 0 | 0 | $0 |
| Jaume Pons | PRESIDENT & CSO | 19. Februar 2025 S | 579.388 | 0 | 0 | $0 |
| Shelly Pinto | SVP, FINANCE AND CAO | 17. August 2026 S | 87.828 | 0 | 5 | $-11.570 |
| Jeff E. Knight | Chief Dev & Operating Officer | 16. April 2026 A | · | 0 | 0 | $0 |
| Barbara Klencke | Chief Medical Officer | 16. April 2026 A | · | 0 | 0 | $0 |
| Sophia Randolph | CHIEF MEDICAL OFFICER | 14. August 2024 S | 325.711 | 0 | 0 | $0 |
| Nathan Caffo | Chief Business Officer | 21. Juli 2020 C | 11.254 | 0 | 0 | $0 |
| Steffen Pietzke | VP Fin & Chief Acct Officer | 21. Juli 2020 P | 3.000 | 0 | 0 | $0 |
| Daniel J. Curran | Direktor | 20. Januar 2026 A | · | 0 | 0 | $0 |
| Alan B. Sandler | Direktor | 20. Januar 2026 A | · | 0 | 0 | $0 |
| Rekha Hemrajani | Direktor | 20. Januar 2026 A | 33.000 | 0 | 0 | $0 |
| Chris H Takimoto | Direktor | 20. Januar 2026 A | · | 0 | 0 | $0 |
| Scott J. Garland | Direktor | 20. Januar 2026 A | · | 0 | 0 | $0 |
| Itziar Canamasas | Direktor | 20. Juni 2023 A | · | 0 | 0 | $0 |
| Jack Nielsen | Direktor | 20. Juni 2023 A | · | 0 | 0 | $0 |
| Graham Walmsley | Direktor | 11. Juni 2021 A | 995.000 | 0 | 0 | $0 |
| Corey S Goodman | · | 2. Februar 2026 P | 8.453.038 | 1 | 0 | $4.999.999 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 12 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,37% | 61.776 SH | 1. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,05% | 366.440 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 1.013.254 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 623.766 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 116.302 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 51.536 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 2.551.278 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 35.778 SH | 29. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 1.343 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.226.065 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.642.854 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.161 SH | 19. August 2026 | Täglich |
ALXO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$4.00
+227,9%
3 23,1%
Starker Kauf
8 61,5%
Kauf
2 15,4%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
5 Analysten · 2026-09-29Mittelwert-Ziel $4.60 +277,0%
← Unter allen Zielen
Aktueller Preis $1.22
Tief$4.00
Mittelwert$4.60
Hoch$6.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| AVXL | · | -16.5 | -36.1% | -991.4% | · | · |
| CMPX | $958M | · | · | · | -45.9% | · |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026